Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Freightos Joins IATA Digitalization Leadership Charter to Advance Modern Air Cargo Connectivity

prnewswire.com
CRGOW CRGO

PowerBank Announces Safe Harbor of 30 MW and 31 MWh of Distributed Solar and Energy Storage Projects

prnewswire.com
SUUN PBK

OKX Launches X-Perps on the Magnificent 7 Stocks, Gold, Silver and Oil for European Traders

businesswire.com
AAPL AMZN GOOGL META MSFT NVDA TSLA

Athena Provides Updates Across Gold Portfolio Ready to Announce with Confidence?

newsfilecorp.com
ATHA ORLA KGC

FingerMotion Enters Edge AI Inference Compute Market Through Strategic MOU with BlueFlare Energy Solutions; Plans to Proceed with First Behind-the-Meter Site (PR1) in Alberta Under Non-Binding Commercial Term Sheet Ready to Announce with Confidence?

newsfilecorp.com
FNGR

Ballou named among Europe's best PR agencies while expanding U.S. client portfolio

globenewswire.com
DUOL COUR CLFD META NOW PINS BOX

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

globenewswire.com
ATHE

UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite

prnewswire.com
VEEV

UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite

prnewswire.com
VEEV

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine

globenewswire.com
IVVD
View all news →